Skip to content
OpenCapital
Get started

Fulgent Genetics, Inc. FLGT Q3 2025 earnings

Reported November 7, 2025 · Before market open

Revenue$84.1MMiss by $1.3M
EPS$0.14Beat by $0.38
Revenue estimate$85.4M
EPS estimate-$0.24

Next report

Jul 30, 2026 (Tomorrow)
Revenue estimate$94.0M
EPS estimate-$0.46

Financials

Q3 2025

Income statement

See full
Revenue$84.1M+17.2%
Gross profit$35.5M+32.7%
Operating income-$15.4M+10.1%
Net income-$6.6M+54.9%
EPS (diluted)-$0.21+56.3%

Balance sheet

See full
Cash & equivalents$117.6M+103%
Total debt$5.6M-21.1%
Total equity$1.1B-1.1%
Total assets$1.2B-1.6%

Cash flow

See full
CapEx$6.1M-69.0%
Free cash flow-+100%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$691.76M+5.1%
Enterprise value$579.68M-4.6%
P/S2.2×-0.2×

Profitability

See full
Gross margin41.2%+5.0pp
Operating margin-22.5%-9.3pp
Net margin-13.6%-5.9pp

Returns & leverage

See full
Return on equity-3.8%-1.6pp
Debt / equity0×0.0×
Current ratio7×+2.6×

Segments

By segment

See full
Laboratory Services$83.9M+17.0%
Therapeutic Development$138.0K—

By geography

See full
Non Us$6.5M+7.0%
Other Countries$3.3M+2.4%

Versus estimates

Revenue

Q1 2026$71.1MBeat by $3.0MQ4 2025$83.3MMiss by $2.0M
Q3 2025$84.1MMiss by $1.3M
Q2 2025$81.8MBeat by $373.0KQ1 2025$73.5MMiss by $3.5MQ4 2024$76.2MBeat by $821.4K

Diluted EPS

Q1 2026-$0.36Miss by $0.01Q4 2025$0.16Beat by $0.13
Q3 2025$0.14Beat by $0.38
Q2 2025$0.07Beat by $0.30Q1 2025$0.04Beat by $0.23Q4 2024$0.04Beat by $0.35

Ask the moment Fulgent Genetics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Fulgent Genetics, Inc. report Q3 2025 earnings?
Fulgent Genetics, Inc. (FLGT) reported Q3 2025 earnings on November 7, 2025 before market open.
What were Fulgent Genetics, Inc.'s Q3 2025 revenue and EPS?
Fulgent Genetics, Inc. reported revenue of $84.1M and eps of $0.14 for Q3 2025.
Did Fulgent Genetics, Inc. beat estimates in Q3 2025?
Revenue missed the consensus estimate of $85.4M by $1.3M. EPS beat the consensus estimate of $-0.24 by $0.38.
How did Fulgent Genetics, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 17.2% from $71.7M a year earlier and eps declined 54.8% from $0.31.
Where can I find Fulgent Genetics, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-271006) and the 10-Q periodic report (0001193125-25-271013) directly on SEC EDGAR. The filing index links above go to sec.gov.